Neuphoria Therapeutics Inc已确认,公司正与Scancell就一项潜在的收购交易进行讨论。若交易达成,Scancell将借此机会实现在纳斯达克市场的上市。
Neuphoria Therapeutics Inc已确认,公司正与Scancell就一项潜在的收购交易进行讨论。若交易达成,Scancell将借此机会实现在纳斯达克市场的上市。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.